Literature DB >> 16314739

Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour?

Johannes H W de Wilt1, Sarah E J Farmer, Richard A Scolyer, Brian C McCaughan, John F Thompson.   

Abstract

Patients with no history of melanoma occasionally present with apparently metastatic melanoma in the lungs, but have no evidence of a primary melanoma. The aims of this study were to investigate the role of surgical resection in the treatment of such patients, and to examine the evidence for a diagnosis of primary pulmonary melanoma in each case. Patients with an unknown primary melanoma who presented with pulmonary disease and subsequently underwent surgical resection were identified from the Sydney Melanoma Unit database. Fifteen patients fulfilled the study criteria. Multiple lesions were present in four. Eight wedge resections and 10 lobectomies were performed. The patients' median survival was 32 months and the 5-year actuarial survival was 42%. This compares with the overall Sydney Melanoma Unit experience of lung resection for melanoma in 83 patients, where the median survival was 19 months and the 5-year survival was 22%. Resection of pulmonary disease in melanoma patients with an unknown primary lesion can result in long-term survival, and even apparent cure. It is possible that some of the patients in this series had primary melanoma of the lung, but this is impossible to prove.

Entities:  

Mesh:

Year:  2005        PMID: 16314739     DOI: 10.1097/00008390-200512000-00008

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

2.  Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.

Authors:  Klaus J Busam; Natasha Rekhtman; Chen Yang; Francisco Sanchez-Vega; Jason C Chang; Walid K Chatila; Alexander N Shoushtari; Marc Ladanyi; William D Travis
Journal:  Mod Pathol       Date:  2020-06-24       Impact factor: 7.842

3.  [Melanoma endobronchial ].

Authors:  Mounia Serraj; Kaoutar Znati; Loubna Nfissi; Mériem Meziane; Ilham ChoumiIlham; Bouchra Amara; Mohammed El Biaze; Afaf Amarti; Fatima Zohra Mernissi; Mohammed Chakib Benjelloun
Journal:  Pan Afr Med J       Date:  2010-08-09

4.  Aggressive behaviour of metastatic melanoma in a patient with neurofibromatosis type 1.

Authors:  Robert W Foley; Robert M Maweni; Aurelie Fabre; David G Healy
Journal:  Case Rep Surg       Date:  2015-03-29

Review 5.  Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments.

Authors:  Kermit S Zhang; Tomer Pelleg; Sabrina Campbell; Catalina Rubio; Anthony Lukas Loschner; Susanti Ie
Journal:  Melanoma Manag       Date:  2021-07-09

6.  Malignant melanoma with indiscoverable skin manifestations presenting with paresis and refractory hypercalcemia: A case report.

Authors:  Pei-Pei Wang; Xi Zhou; Xi Chen; Li-Wen Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

7.  Primary Melanoma of the Lung: A Systematic Review.

Authors:  Panagiotis Paliogiannis; Antonella M Fara; Gianfranco Pintus; Wael M Abdel-Rahman; Maria Colombino; Milena Casula; Giuseppe Palmieri; Antonio Cossu
Journal:  Medicina (Kaunas)       Date:  2020-10-30       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.